compound, pharmaceutical composition and method of disruption of nek2 / hec1 interaction

• 收藏
• 分享

专利权人:

TAIVEX THERAPEUTICS INC.

发明人:

JIANN-JYH HUANG,JOHNSON LAU

申请号：

BR112012023355

公开号：

BR112012023355A2

申请日:

2011.03.15

申请国别(地区):

BR

年份:

2016

代理人:

摘要：

Compounds, compositions, and methods for modulation of Hec1/Nek2 interaction are provided. Especially preferred compounds disrupt Nek2/Hec1 binding and are therefore useful as chemotherapeutic agent for neoplastic diseases.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/